Literature DB >> 28316065

Identification of key genes and construction of microRNA-mRNA regulatory networks in multiple myeloma by integrated multiple GEO datasets using bioinformatics analysis.

Hongyu Gao1, Huihan Wang1, Wei Yang2.   

Abstract

Multiple myeloma (MM) is a common hematological malignancy. To identify key genes and microRNAs in MM, we downloaded two gene expression profiles (GSE16558 and GSE47552) and two microRNA expression profiles (GSE17498 and GSE16558) from the Gene Expression Omnibus (GEO) database. A total of 596 differentially expressed genes (DEGs) and 39 differentially expressed microRNAs (DEMs) were screened out. Pathway analysis showed that upregulated genes were mainly enriched in the "B cell receptor signaling pathway", "Cell cycle" and "NF-kappa B signaling pathway", whereas downregulated genes were mainly enriched in the "Ribosome", "FoxO signaling pathway" and "p53 signaling pathway". We subsequently constructed a protein-protein interaction network of DEGs consisting of 277 genes and 563 interactions. In addition, 32 genes with high degrees in the network were identified as hub genes in MM, e.g. HDAC2, RBBP4, CREB1, and RB1. Additionally, we constructed a microRNA-mRNA regulatory network depicting interactions between DEMs and their targets, including the miR-135b-GADD45A and miR-148a-USPL1 pairs. In conclusion, the results of this data mining and integration help reveal the molecular basis of MM pathogenesis as well as potential biomarkers and therapeutic targets for MM diagnosis and treatment.

Entities:  

Keywords:  Functional enrichment analysis; MicroRNA; Multiple myeloma; Protein–protein interaction

Mesh:

Substances:

Year:  2017        PMID: 28316065     DOI: 10.1007/s12185-017-2216-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  44 in total

Review 1.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 3.  Histone deacetylases: salesmen and customers in the post-translational modification market.

Authors:  André Brandl; Thorsten Heinzel; Oliver H Krämer
Journal:  Biol Cell       Date:  2009-04       Impact factor: 4.458

Review 4.  Multiple myeloma.

Authors:  Antonio Palumbo; Kenneth Anderson
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

5.  The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.

Authors:  Naïma Hanoun; Yannick Delpu; Arief A Suriawinata; Barbara Bournet; Christophe Bureau; Janick Selves; Gregory J Tsongalis; Marlène Dufresne; Louis Buscail; Pierre Cordelier; Jérôme Torrisani
Journal:  Clin Chem       Date:  2010-04-29       Impact factor: 8.327

6.  Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma.

Authors:  Patryk Krzeminski; María E Sarasquete; Irena Misiewicz-Krzeminska; Rocío Corral; Luis A Corchete; Ana A Martín; Ramón García-Sanz; Jesús F San Miguel; Norma C Gutiérrez
Journal:  Biochim Biophys Acta       Date:  2014-12-11

7.  Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.

Authors:  Sridurga Mithraprabhu; Anna Kalff; Annie Chow; Tiffany Khong; Andrew Spencer
Journal:  Epigenetics       Date:  2014-11       Impact factor: 4.528

8.  Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.

Authors:  Kavitha Ramachandran; Gopal Gopisetty; Edna Gordian; Loida Navarro; Christiane Hader; Isildinha M Reis; Wolfgang A Schulz; Rakesh Singal
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

9.  APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma.

Authors:  Brian A Walker; Christopher P Wardell; Alex Murison; Eileen M Boyle; Dil B Begum; Nasrin M Dahir; Paula Z Proszek; Lorenzo Melchor; Charlotte Pawlyn; Martin F Kaiser; David C Johnson; Ya-Wei Qiang; John R Jones; David A Cairns; Walter M Gregory; Roger G Owen; Gordon Cook; Mark T Drayson; Graham H Jackson; Faith E Davies; Gareth J Morgan
Journal:  Nat Commun       Date:  2015-04-23       Impact factor: 14.919

10.  Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells.

Authors:  Jianyun Zhao; Chengzhi Xie; Holly Edwards; Guan Wang; Jeffrey W Taub; Yubin Ge
Journal:  Oncotarget       Date:  2017-01-24
View more
  8 in total

1.  Comprehensive analysis of long non-coding RNA PVT1 gene interaction regulatory network in hepatocellular carcinoma using gene microarray and bioinformatics.

Authors:  Yu Zhang; Yi-Wu Dang; Xiao Wang; Xia Yang; Rui Zhang; Zi-Li Lv; Gang Chen
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

2.  Identification of G2 and S Phase-Expressed-1 as a Potential Biomarker in Patients with Prostate Cancer.

Authors:  Jian Xiong; Jianzhong Zhang; Hongjun Li
Journal:  Cancer Manag Res       Date:  2020-09-28       Impact factor: 3.989

3.  Long non‑coding RNA HOTTIP promotes hepatocellular carcinoma tumorigenesis and development: A comprehensive investigation based on bioinformatics, qRT‑PCR and meta‑analysis of 393 cases.

Authors:  Yu Zhang; Jia-Cheng Huang; Kai-Teng Cai; Xi-Bing Yu; You-Rong Chen; Wen-Ya Pan; Ze-Liang He; Jun Lv; Zhen-Bo Feng; Gang Chen
Journal:  Int J Oncol       Date:  2017-10-16       Impact factor: 5.650

4.  Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma.

Authors:  Ya Guo; Yang Zhang; Shu Juan Zhang; Yi Nan Ma; Yun He
Journal:  BMC Med Genomics       Date:  2019-05-28       Impact factor: 3.063

5.  Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis.

Authors:  Jinwei Liu; Zhaojin Yu; Mingli Sun; Qianqian Liu; Minjie Wei; Hua Gao
Journal:  Oncol Lett       Date:  2019-09-05       Impact factor: 2.967

6.  Structural basis for the SUMO protease activity of the atypical ubiquitin-specific protease USPL1.

Authors:  Ying Li; Nathalia Varejão; David Reverter
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 17.694

7.  Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical Analysis

Authors:  Lihong Liu; Fangxu Chen; Aihui Xiu; Bo Du; Hao Ai; Wei Xie
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-25

8.  Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data.

Authors:  Amit Katiyar; Gurvinder Kaur; Lata Rani; Lingaraja Jena; Harpreet Singh; Lalit Kumar; Atul Sharma; Punit Kaur; Ritu Gupta
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.